1996

Abstract

This information note seeks to facilitate access to information on possible trade-related bottlenecks and trade-facilitating measures on critical products to combat COVID-19, including inputs used in vaccine manufacturing, vaccine distribution and approval, therapeutics and pharmaceuticals, diagnostics and medical devices. It is not meant to be an exhaustive list of all specific trade barriers, nor does it make any judgement on the existence or importance of bottlenecks, nor on the desirability of implementing any of the suggestions on trade-facilitating measures.

Loading

Article metrics loading...

/content/papers/27095819/22
2021-07-20
2024-11-08
http://instance.metastore.ingenta.com/content/papers/27095819/22
Loading
  • Published online: 20 Jul 2021
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
aHR0cHM6Ly93d3cud3RvLWlsaWJyYXJ5Lm9yZy8K